Glaukos Corp. (GKOS)
113.23
+0.71
(+0.63%)
USD |
NYSE |
Feb 09, 16:00
113.23
0.00 (0.00%)
After-Hours: 17:34
Glaukos EPS Diluted (Quarterly) : -0.2828 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Intuitive Surgical, Inc. | 2.205 |
| ResMed, Inc. | 2.682 |
| Abbott Laboratories | 1.017 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -16.23M |
| Revenue (Quarterly) | 133.54M |
| Total Expenses (Quarterly) | 149.77M |
| Enterprise Value | 6.293B |
| Gross Profit Margin (Quarterly) | 78.41% |
| Profit Margin (Quarterly) | -12.15% |
| Earnings Yield | -1.37% |
| Normalized Earnings Yield | -1.370 |